Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Florence
Clinical trial register · Italy

Clinical Trials in Florence, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca57 Meyer Children's Hospital IRCCS41 Merck Sharp & Dohme LLC25 Eli Lilly and Company25 Novartis Pharmaceuticals24
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Florence

787 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Princess Maxima Center for Pediatric Oncology
Phase 3
160
Florence, Naples, Roma, Torino, Trieste, Verona
2022-12-15
Active, closed
Amgen
Phase 3
7,297
Arzignano, Bologna, Brescia, Caserta, Catania, Catanzaro, Cona FE, Florence
2022-12-14
Active, closed
Bristol-Myers Squibb
Phase 2/3
230
Rome, Rozzano, Florence, Bologna
2022-12-14
Active, closed
Dizal Pharmaceuticals
Phase 3
324
Aviano, Bologna, Catania, Florence, Grosseto, Meldola, Modena, Monza
2022-12-13
Active, closed
Hemab ApS
Phase 1/2
57
Florence, Milan
2022-12-13
Recruiting
Gilead Sciences
Phase 3
1,514
Bari, Bologna, Florence, Genova, Meldola, Milan, Misterbianco, Modena
2022-12-12
Recruiting
Iacopo Sardi
Phase 2
20
Florence
2022-12-09
Recruiting
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
NCT05524298Low Grade Non-Hodgkin's Lymphoma, Adult
Fondazione Italiana Linfomi - ETS
Observational
150
Alessandria, Ancona, Bari, Brescia, Castelfranco Veneto, Catania, Florence, Messina
2022-12-07
Recruiting
Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults
NCT06621810Melanoma (Skin Cancer), Artificial Intelligence (AI), Pediatric Cancer
German Cancer Research Center
Observational
3,000
Florence
2022-12-01
By invitation
Ionis Pharmaceuticals, Inc.
Phase 3
1,400
Ancona, Florence, Padova, Pavia, Pisa, Roma
2022-11-30
Active, closed
AstraZeneca
Phase 3
1,174
Bologna, Brescia, Florence, Genova, Livorno, Meldola, Messina, Milan
2022-11-28
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
297
Ancona, Florence, Genova, Messina, Milan, Naples, Orbassano, Potenza
2022-11-23
Active, closed
Mirati Therapeutics Inc.
Phase 2
90
Avellino, Casale Monferrato, Florence, Milan, Orbassano, Ravenna, Roma
2022-11-22
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
260
Bergamo, Brescia, Florence, Milan, Naples, Palermo, Pisa, Roma
2022-11-21
Recruiting
Bayer
Phase 3
100
Bologna, Florence, Genova, Milan, Roma, Torino
2022-11-08
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
822
Ancona, Florence, Genova, Milan, Orbassano, Potenza, Verona
2022-11-08
Active, closed
Type I Diabetes and Non-surgical Periodontal Treatment
NCT05569525Type 1 Diabetes, Periodontitis, Periodontal Diseases, Diabetes
University of Florence
Not applicable
100
Florence
2022-11-06
Recruiting
Associazione Qol-one
Phase 2
22
Alessandria, Ancona, Avellino, Biella, Catania, Chivasso, Cosenza, Florence
2022-11-03
Recruiting
Validation Fugl-Meyer in Italian Language (FMI)
NCT04117997Validation Fugl-Meyer Scale in Italian
Fondazione Don Carlo Gnocchi ETS
Observational
70
Florence
2022-11-01
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
80
Avellino, Bassano del Grappa, Florence, Milan, Reggio Calabria, Roma
2022-10-28
Recruiting
Regeneron Pharmaceuticals
Observational
500
Misterbianco, Florence, Udine, Rozzano, Orbassano, Pisa, Catania, Milan
2022-10-26
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Bergamo, Bologna, Florence, Milan, Naples, Pavia, Roma, Rozzano
2022-10-25
Active, closed
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
NCT05587296Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer
Phase 3
474
Naples, Modena, Rome, Genoa, Milan, Pavia, Turin, Florence
2022-10-14
Active, closed
Eli Lilly and Company
Phase 3
15,374
Bari, Bologna, Como, Ferrara, Florence, Latina, Padova, Palermo
2022-10-11
Active, closed
Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients
NCT05306301Chemotherapy, Leukemia, Acute Lymphoblastic
DrugPonatinib
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
32
Avellino, Pagani, Bergamo, Bologna, Brescia, Catania, Florence, Lecce
2022-10-05
Active, closed
Eli Lilly and Company
Phase 3
8,000
Ancona, Bergamo, Bologna, Brindisi, Candiolo, Florence, Genova, Milan
2022-10-04
Active, closed
Genmab
Phase 1
17
Florence, Monza, Rome
2022-10-04
Active, closed
Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder
NCT05373719Cyclin-Dependent Kinase-Like 5 Deficiency Disorder
Loulou Foundation
Observational
112
Florence, Roma, Rome, Verona
2022-09-30
Recruiting
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
NCT05377047Breast Cancer Stage IV, Oligometastatic Disease
Vastra Gotaland Region
Phase 3
345
Florence, Milan
2022-09-19
Active, closed
Biogen
Phase 2/3
450
Bologna, Brescia, Florence, Genova, Milan, Naples, Roma
2022-09-13
Recruiting
Universitaire Ziekenhuizen KU Leuven
Phase 4
292
Milan, Castellana Grotte, Florence
2022-09-08
Recruiting
AstraZeneca
Phase 2
454
Florence, Genova, Milan, Naples, Rome
2022-09-06
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
845
San Giovanni Rotondo, Milan, Rozzano, Roma, Torino, Florence, Palermo, Pisa
2022-08-26
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
410
Salerno, Rome, Baggiovara, Ponderano (Biella), Florence, Milan, Monza, Pisa
2022-08-23
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Bologna, Florence, Forlì, Milan, Misterbianco, Naples, Padova, Pisa
2022-08-17
Active, closed
Novo Nordisk A/S
Phase 3
412
Milan, Florence, Genova, Naples, Roma, Rome
2022-08-10
Active, closed
Regeneron Pharmaceuticals
Phase 3
202
Florence, Rome, Turin
2022-08-01
Active, closed
Cross-linked Volume-stable Collagen Matrix Versus Connective Tissue Graft At Implant Site.
NCT05458271Edentulous Alveolar Ridge Atrophy, Soft Tissue Augmentation At Dental Implants
University of Florence
Not applicable
100
Florence
2022-07-31
Recruiting
Azienda Ospedaliero-Universitaria Careggi
Not applicable
33
Florence
2022-07-19
Active, closed
GlaxoSmithKline
Phase 3
163
Bari, Brescia, Florence, Milan, Pavia, Pisa, Roma, Torrette AN
2022-07-14
Active, closed
Merck Sharp & Dohme LLC
Phase 2
60
Rome, Milan, Palermo, Florence, Alessandria
2022-07-14
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
28
Ancona, Aviano, Florence, Miano, Monza, Naples, Roma, Palermo
2022-07-11
Recruiting
AIOCC Italian Registry on Head and Neck Carcinomas
NCT06248944Head and Neck Carcinoma
Italian Head&Neck Society
Observational
7,000
Candiolo, Florence, Lecce, Milan, Pavia, Roma, Verona
2022-07-06
Recruiting
Azienda Ospedaliera di Padova
Observational
46
Bologna, Brescia, Florence, Genova, Padova, Roma
2022-07-01
Active, closed
Cogent Biosciences, Inc.
Phase 2
237
Bologna, Catania, Florence, Pavia, Ravenna
2022-06-27
Active, closed
Hoffmann-La Roche
Phase 4
136
Naples, Rome, Milan, Florence
2022-06-20
Recruiting
Priothera SAS
Phase 3
366
Brindisi, Reggio Calabria, San Giovanni Rotondo, Lecce, Roma, Alessandria, Ascoli Piceno, Florence
2022-06-16
Recruiting
IRCCS Burlo Garofolo
Observational
20
Florence, Milan, Trieste
2022-06-13
Recruiting
BioMarin Pharmaceutical
Observational
450
Bologna, Florence, Milan, Naples, Padova, Palermo, Rome
2022-06-06
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
49
Bologna, Viagrande, Meldola, Florence, Rozzano, Padova, Aviano, Roma
2022-05-27
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Florence, Genova, Milan, Padova, Pavia, Roma, Torino, Trieste
2022-05-23
Recruiting
Electra Therapeutics Inc.
Phase 2/3
156
Florence, Genova, Milan, Monza, Padova, Roma, Trieste
2022-05-19
Recruiting
Groupe Francophone des Myelodysplasies
Phase 1/2
150
Candiolo, Florence
2022-05-18
Recruiting
SK Life Science, Inc.
Phase 3
252
Genoa, Milan, Verona, Florence
2022-04-28
Recruiting
Cogent Biosciences, Inc.
Phase 3
482
Aviano, Bologna, Brescia, Candiolo, Florence, Meldola, Milan, Palermo
2022-04-14
Recruiting
AstraZeneca
Phase 2
630
Aviano, Brescia, Catanzaro, Florence, Genova, Meldola, Milan, Monza
2022-04-14
Recruiting
Zimmer Biomet
Observational
500
Bari, Florence
2022-04-11
Active, closed
Protagonist Therapeutics, Inc.
Phase 3
293
Meldola, Bergamo, Bologna, Brescia, Florence, Milan, Pavia, Pesaro
2022-04-01
Active, closed
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
154
Turin, Florence, Genova, Milan, Pavia, Reggio Emilia, Roma
2022-03-29
Active, closed
AstraZeneca
Phase 3
760
Arezzo, Florence, Milan, Roma, Rozzano, Tricase
2022-03-28
Active, closed
Bayer
Phase 3
219
Bologna, Florence, Genova, Milan, Roma, Torino
2022-03-28
Active, closed
Novo Nordisk A/S
Phase 3
153
Catania, Florence, Padova, Parma
2022-03-24
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
49
Brescia, Alessandria, Cuneo, Florence, Genova, Milan, Naples, Novara
2022-03-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Bari, Meldola, Rome, Milan, Orbassano, Florence, Arezzo, Bologna
2022-03-15
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Bologna, Brescia, Florence, Genova, Messina, Milan, Naples, Pavia
2022-03-15
Active, closed
BeOne Medicines
Phase 3
799
Aviano, Bologna, Florence, Milan, Novara, Padova, Pavia, Reggio Emilia
2022-03-10
Active, closed
A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.
NCT05064878CDKL5 Deficiency Disorder, Generalized Tonic Clonic Seizure, Epileptic Spasm, Refractory Seizures
DrugFintepla
Zogenix, Inc.
Phase 3
87
Florence, Genova, Modena, Roma, Verona
2022-03-08
Active, closed
An Integrated Radio-immunological Approach
NCT05267509Glioma, Malignant
Istituto Oncologico Veneto IRCCS
Observational
31
Florence, Padova
2022-02-23
Active, closed
AstraZeneca
Phase 3
390
Bari, Catania, Florence, Genova, Milan, Naples, Padova, Parma
2022-02-21
Recruiting
Sanofi
Phase 3
284
Cona, Florence, Milan, Rozzano, Naples, Rome, Ancona
2022-02-15
Recruiting
Meyer Children's Hospital IRCCS
Observational
290
Florence, Bari, Brescia, Catanzaro, Lecce, Milan, Padova, Pavia
2022-02-10
Recruiting
Azienda Ospedaliero-Universitaria Careggi
Not applicable
60
Florence
2022-02-07
Active, closed
AstraZeneca
Phase 3
1,051
Brescia, Florence, Lucca, Meldola, Orbassano, Parma, Pavia, Roma
2022-02-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
280
Naples, Bologna, Meldola, Milan, Turin, Rome, Florence, Vicenza
2022-02-03
Active, closed
Denali Therapeutics Inc.
Phase 1/2
85
Brescia, Florence, Milan, Tricase
2022-02-01
Recruiting
ARCAGY/ GINECO GROUP
Phase 2
390
Florence, Milan, Monza, Sondrio
2022-02-01
Active, closed
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
NCT05002127Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma
DrugsEvorpacept·Ramucirumab·Herceptin·Taxol
ALX Oncology Inc.
Phase 2/3
127
Catania, Florence, Milan, Roma, Udine
2022-01-15
Recruiting
Fondazione Don Carlo Gnocchi ETS
Observational
600
Florence, Milan, Parma, Rovato
2022-01-12
Active, closed
Noema Pharma AG
Phase 2/3
166
Rome, Florence, Milan
2022-01-11
Active, closed
Ascendis Pharma Oncology Division A/S
Phase 1/2
320
Cuneo, Florence, Grosseto, Lido di Camaiore, Livorno, Meldola, Milan, Modena
2022-01-11
Recruiting
Azienda Ospedaliero-Universitaria Careggi
Observational
10,000
Bari, Bologna, Florence, Foggia, Genova, Messina, Milan, Naples
2022-01-10
Active, closed
Washington University School of Medicine
Phase 2/3
197
Brescia, Florence
2021-12-22
Active, closed
Novartis Pharmaceuticals
Phase 3
210
Bari, Bergamo, Bologna, Florence, Genova, Milan, Rozzano, Palermo
2021-12-17
Recruiting
Takeda
Phase 2
135
Bari, Bologna, Brescia, Florence, Genova, Milan, Reggio Emilia, Roma
2021-12-16
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT05176483Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor
DrugsZanzalintinib·Relatlimab·Yervoy·Ipilimumab
Exelixis
Phase 1
1,394
Ancona, Bologna, Florence, Milan, Naples, Ravenna
2021-12-14
Active, closed
University Hospital, Basel, Switzerland
Not applicable
543
Bologna, Florence, Naples, Torino
2021-12-09
Recruiting
H. Lundbeck A/S
Phase 3
600
Rome, Genoa, Milan, Cagliari, Florence, Pisa, Pavia
2021-12-01
Recruiting
Blueprint Medicines Corporation
Phase 2/3
534
Milan, Florence, Bologna, Catania, Pavia, Salerno, Verona, Vicenza
2021-11-30
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Bologna, Brescia, Cona, Florence, Grosseto, Pozzilli, Milan, Rozzano
2021-11-23
Recruiting
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
NCT04996875Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Neoplasm (SM-AHN), Mast Cell Leukemia (MCL), Aggressive Systemic Mastocytosis (ASM)
DrugBezuclastinib
Cogent Biosciences, Inc.
Phase 2
140
Bologna, Florence, Salerno, Verona
2021-11-09
Active, closed
AstraZeneca
Phase 3
148
Arezzo, Avellino, Bari, Bologna, Florence, Meldola, Milan, Naples
2021-10-28
Active, closed
Hoffmann-La Roche
Phase 3
478
Bologna, Ravenna, Palermo, Ancona, Florence, Padova
2021-10-27
Active, closed
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
NCT04988386Amyloid Cardiomyopathy, Transthyretin-Related
DrugAcoramidis
Eidos Therapeutics, a BridgeBio company
Phase 3
389
Arezzo, Florence, Pisa, Pavia
2021-10-27
Recruiting
argenx
Phase 2/3
12
Bari, Florence, Genova
2021-10-26
Active, closed
Camurus AB
Phase 3
332
Bari, Bologna, Brescia, Florence, Genova, Meldola, Milan, Modena
2021-10-22
Active, closed
AstraZeneca
Phase 3
732
Bologna, Candiolo, Florence, Meldola, Milan, Naples, Padova, Prato
2021-10-18
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Bari, Bergamo, Bologna, Florence, Meldola, Pavia, Roma, Turin
2021-10-14
Recruiting
Study on the Diagnosis and Management of CLL in Italy by GIMEMA
NCT04867915Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, MBL-CLL - Monoclonal B-Cell Lymphocytosis Chronic Lymphocytic Leukaemia-Type
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
12,500
Alessandria, Brescia, Brindisi, Candiolo, Florence, Messina, Mestre, Milan
2021-10-13
Active, closed
Fondazione Ricerca Traslazionale
Phase 2
105
Meldola, Saronno, Legnago, Negrar, Civitavecchia, Florence, Messina, Novara
2021-10-12
Recruiting
Niguarda Hospital
Phase 3
288
Ancona, Bergamo, Bologna, Brescia, Cagliari, Chieti, Florence, Genova
2021-10-07
Active, closed
Eli Lilly and Company
Phase 3
874
Naples, Aviano, Rome, Genoa, Florence, Padova
2021-10-04
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Bologna, Catanzaro, Cona, Cuneo, Florence, Meldola, Milan, Modena
2021-09-20
Recruiting
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
Not applicable
78
Arezzo, Florence, Genova, Milan, Palermo, Perugia, Pistoia
2021-09-14
Active, closed
Spanish Breast Cancer Research Group
Phase 3
27
Alessandria, Ancona, Bolzano, Castellanza, Catania, Cremona, Florence, Genoa
2021-09-14
Active, closed
AstraZeneca
Phase 3
98
Florence, Meldola, Messina, Naples, Padova, Roma, Terni, Verona
2021-09-12
Active, closed
Albireo, an Ipsen Company
Phase 3
62
Florence, Padova, Rome
2021-09-03
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Bari, Campobasso, Catanzaro, Florence, Naples, Palermo, Pisa, Potenza
2021-08-25
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Arezzo, Bologna, Caserta, Catania, Catanzaro, Cona, Florence, Messina
2021-08-14
Active, closed
AstraZeneca
Phase 3
712
Bari, Florence, Meldola, Milan, Padova, Pozzuoli, Reggio Emilia, Roma
2021-08-05
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
800
Ancona, Cremona, Empoli, Florence, Milan, Perugia, Treviso
2021-08-04
Recruiting
Observational Study in Localized Osteosarcoma
NCT04890067Localized Osteosarcoma
Italian Sarcoma Group
Observational
120
Aviano, Candiolo, Trieste, Bari, Bologna, Catania, Florence, Genova
2021-07-30
Active, closed
Novartis Pharmaceuticals
Phase 3
208
Ascoli Piceno, Avellino, Florence, Milan, Roma, Torino, Bassano del Grappa
2021-07-27
Active, closed
Bristol-Myers Squibb
Phase 3
729
Florence, Potenza, Roma
2021-07-15
Active, closed
Hoffmann-La Roche
Phase 3
451
Chieti, Bari, Trieste, Rome, Milan, Torrette - Ancona, Florence, Perugia
2021-07-14
Recruiting
Meyer Children's Hospital IRCCS
Observational
103
Bergamo, Brescia, Florence, Genova, Milan, Palermo, Torino, Trieste
2021-07-13
Active, closed
AstraZeneca
Phase 3
315
Bergamo, Bologna, Florence, Meldola, Milan, Misterbianco, Naples, Padova
2021-06-30
By invitation
Philips Clinical & Medical Affairs Global
Not applicable
3,212
Florence
2021-06-17
Recruiting
Meyer Children's Hospital IRCCS
Observational
300
Florence, Genova
2021-06-15
Active, closed
Sanofi
Observational
16
Monza, Florence
2021-06-10
Recruiting
Fondazione Don Carlo Gnocchi ETS
Observational
30
Florence
2021-06-09
Active, closed
Galecto Biotech AB
Phase 2
21
Bologna, Florence, Milan, Orbassano, Varese
2021-06-09
Recruiting
Observational Study on Skeletal Ewing's Sarcoma
NCT04845893Ewing Sarcoma of Bone
Italian Sarcoma Group
Observational
100
Rozzano, Aviano, Candiolo, Bari, Bologna, Florence, Genova, Milan
2021-06-01
By invitation
Policlinic Hospital "G. Rodolico"
Observational
200
Catania, Florence, Torino, Varese
2021-06-01
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
DrugMirikizumab
Eli Lilly and Company
Phase 3
150
Bergamo, Bologna, Florence, Milan, Roma, Rome
2021-05-26
Active, closed
Bristol-Myers Squibb
Phase 3
681
Cremona, Florence, Meldola, Milan, Padova, Parma, Pavia, Roma
2021-05-21
Active, closed
AstraZeneca
Phase 3
893
Bologna, Florence, Misterbianco, Naples, Padova, Prato, Roma
2021-05-10
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
NCT04614103Metastatic Non Small Cell Lung Cancer
Iovance Biotherapeutics, Inc.
Phase 2
170
Florence, Pavia, Pesaro, Piemonte
2021-05-07
By invitation
Cytokinetics
Phase 2/3
900
Florence, Milan, Naples, Pisa, Roma, Trieste
2021-05-06
Active, closed
Murdoch Childrens Research Institute
Not applicable
906
Monza, Varese, Florence, Milan, Rome
2021-05-04
Recruiting
COL4A1COL4A2: Study of Pathological Conditions Involving Multiple Organs Caused by Mutations in the COL4A1 and COL4A2 Genes
NCT07374913COL4A1\2, COL4A1-Related Brain Small Vessel Disease With Haemorrhage
Meyer Children's Hospital IRCCS
Not applicable
120
Florence
2021-05-01
Recruiting
Robotic Radical Cystectomy Outcomes
NCT04900558Bladder Cancer, Muscle-Invasive Bladder Carcinoma, Oncology, Recurrence
University of Florence
Observational
500
Florence
2021-04-29
Active, closed
Hoffmann-La Roche
Phase 3
557
Naples, Bologna, Rome, Milan, Turin, Palermo, Florence, Pisa
2021-04-26
Recruiting
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NCT04796350Fragility Fracture, Hip Fractures, Osteoporosis
AgNovos Healthcare, LLC
Not applicable
2,400
Florence, Milan, Rome, Torino
2021-04-24
Active, closed
Eli Lilly and Company
Phase 3
101
Naples, Genoa, Milan, Florence, Brescia
2021-04-13
Active, closed
Geron Corporation
Phase 3
327
Alessandria, Bologna, Cona, Florence, Genova, Milan, Ravenna, Reggio Calabria
2021-04-12
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
430
Bergamo, Bologna, Brescia, Ferrara, Florence, Meldola, Milan, Monza
2021-04-09
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Catanzaro, San Giovanni Rotondo, Palermo, Bologna, Florence, Foggia, Milan, Roma
2021-04-01
Active, closed
Kedrion S.p.A.
Phase 3
30
Brescia, Florence, Genova, Milan, Naples, Roma
2021-03-31
Active, closed
Bristol-Myers Squibb
Phase 1/2
216
Bologna, Brescia, Florence, Verona
2021-03-22
Active, closed
Karyopharm Therapeutics Inc
Phase 2
112
Meldola, Florence, Latina, Perugia, Varese
2021-03-17
Recruiting
Fondazione EMN Italy Onlus
Observational
1,900
Florence, Ancona, Bari, Bologna, Brescia, Catania, Genova, Milan
2021-03-16
Active, closed
Celgene
Phase 3
313
Meldola (fc), Ancona, Bologna, Brescia, Catania, Florence, Milan, Napoli Campania
2021-02-25
Active, closed
Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms
NCT04279847Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome, Myeloproliferative Neoplasm
DrugRuxolitinib
Incyte Corporation
Phase 1
140
Bologna, Florence, Meldola, Milan, Orbassano, Verona
2021-02-23
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Alessandria, Avellino, Aviano, Bari, Brescia, Candiolo, Catania, Florence
2021-02-23
Active, closed
Stichting European Myeloma Network
Phase 2
160
Ancona, Bologna, Bolzano, Brescia, Florence, Genova, Pavia, Terni
2021-02-22
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicable
38
Bari, Florence, Genova, Perugia, Roma, Rozzano
2021-02-12
Active, closed
Azienda Ospedaliero-Universitaria Careggi
Phase 3
926
Florence
2021-02-08
Active, closed
Hoffmann-La Roche
Phase 3
55
Naples, Parma, Milan, Florence
2021-02-04
Recruiting
Epygon
Not applicable
40
Florence, Torino
2021-02-01
Active, closed
AstraZeneca
Phase 3
1,371
Bergamo, Florence, Milan, Modena, Naples, Novara, Padova, Parma
2021-01-28
Recruiting
PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE
NCT05022914Prostate Cancer, Biochemical Relapse Fo Malignant Neoplasm of Prostate, Prostate Adenocarcinoma, Prostate Cancer Recurrent
Azienda Ospedaliero-Universitaria Careggi
Observational
180
Florence
2021-01-19
Recruiting
Secukinumab Open Label Roll-over Extension Protocol
NCT04638647Autoimmunity, Inflammation
DrugSecukinumab
Novartis Pharmaceuticals
Phase 4
1,000
Florence, Reggio Emilia
2020-12-22
Active, closed
Stryker Neurovascular
Observational
405
Florence, Genova, Milan, Rome
2020-12-21
Active, closed
Janssen Research & Development, LLC
Phase 2
220
Bari, Florence, Genova, Milan, Pisa, Roma, Rome, Torino
2020-12-18
Active, closed
Neurocrine Biosciences
Phase 3
182
Ancona, Bologna, Florence, Messina, Milan, Naples, Padova, Roma
2020-12-16
Active, closed
AstraZeneca
Phase 3
358
Bari, Florence, Monza, Orbassano, Padova, Rozzano, Varese
2020-12-16
Active, closed
GlaxoSmithKline
Phase 2/3
758
Ancona, Avellino, Florence, Milan, Monza, Naples, Orbassano to, Perugia
2020-12-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
Modena, Florence, Verona, Brescia, Milan, Padova, Roma
2020-12-08
Active, closed
Amgen
Phase 3
135
Florence, Milan, Pisa, Reggio Emilia, Torino, Verona
2020-12-04
Active, closed
MeiraGTx Ocular UK Ltd
Phase 3
97
Florence, Milan, Naples, Rome
2020-12-04
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Aviano, Bari, Bologna, Brescia, Candiolo, Florence, Genova, Meldola
2020-12-02
Active, closed
University Hospital, Basel, Switzerland
Not applicable
64,374
Florence, Roma, Torino
2020-12-01
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Bologna, Florence, Milan, Roma
2020-11-12
Active, closed
Associazione Italiana per lo Studio del Pancreas
Phase 3
261
Aviano, Bari, Bergamo, Bologna, Brescia, Florence, Meldola, Milan
2020-11-03
Recruiting
Extracorporeal Blood Purification Therapy in Critically Ill Patients (GlobalARRT)
NCT04580680Critical Illness, Acute Kidney Injury, Sepsis, Systemic Inflammatory Response Syndrome
Careggi Hospital
Observational
1,000
Florence
2020-11-01
Recruiting
Occlutech International AB
Observational
150
Florence, Milan
2020-10-28
Active, closed
Exelixis
Phase 3
575
Meldola, Rozzano, Sondrio, Trento, Ancona, Florence, Milan, Parma
2020-10-19
Active, closed
CHAMPION-AF Clinical Trial
NCT04394546Atrial Fibrillation, Stroke, Bleeding
DrugsNon-Vitamin K Anticoagulant·NOAC
Boston Scientific Corporation
Not applicable
3,000
Pisa, Florence, Rivoli, Rozzano
2020-10-15
Active, closed
Medstar Health Research Institute
Not applicable
3,100
Florence, Messina
2020-10-14
Active, closed
Acerta Pharma BV
Phase 3
611
Bari, Bergamo, Bologna, Florence, Genova, Meldola, Milan, Novara
2020-10-08
Active, closed
AstraZeneca
Phase 3
370
Brescia, Candiolo, Florence, Milan, Modena, Naples, Padova
2020-10-02
Active, closed
Hoffmann-La Roche
Phase 3
190
Ravenna, Rome, Milan, Turin, Florence
2020-09-30
Active, closed
European Myeloma Network B.V.
Phase 3
302
Ancona, Bari, Bologna, Brescia, Cuneo, Florence, Novara, Pavia
2020-09-25
Active, closed
argenx
Phase 2
229
Brescia, Florence, Genova, Messina, Milan, Pisa, Roma, Torino
2020-09-18
Active, closed
ADC Therapeutics S.A.
Phase 3
440
Udine, Brescia, Florence, Foggia, Meldola, Milan, Pavia, Ravenna
2020-09-16
Active, closed
AbbVie
Phase 3
330
Bologna, Florence, Rome, Monza, Naples, Turin, Ancona, Bergamo
2020-08-31
Active, closed
Pfizer
Phase 3
77
Roma, Florence, Naples
2020-08-18
Active, closed
Hoffmann-La Roche
Phase 3
271
Bari, Genoa, Brescia, Florence, Padova
2020-08-10
Active, closed
Incyte Corporation
Phase 2
112
Bologna, Florence, Meldola (FC), Milan, Naples, Novara, Palermo, Pisa
2020-08-03
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
321
Cona, Alessandria, Bari, Cagliari, Catania, Catanzaro, Cosenza, Florence
2020-07-24
Active, closed
Novartis Pharmaceuticals
Phase 3
19
Florence
2020-07-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Torrette, Rome, Rozzano, Florence, Lecce, Milan, Modena, Udine
2020-07-06
Active, closed
Epizyme, Inc.
Phase 3
599
Naples, Meldola, Brescia, Catania, Florence, Lecce, Milan, Monza
2020-06-11
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
572
Alessandria, Asti, Bari, Bologna, Cagliari, Florence, Milan, Modena
2020-05-29
Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
NCT04256317Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm, Chronic Myelomonocytic Leukemia
DrugsVenclexta·Azacitidine·Venetoclax
Taiho Oncology, Inc.
Phase 2/3
316
Ravenna, Florence, Torino, Bologna, Milan, Novara, Roma
2020-05-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
520
Bari, Rome, Milan, Florence, Modena, Naples, Province of Macerata
2020-05-19
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Not applicable
60,000
Meldola (FC), Florence, Forlì, Torino
2020-02-06
Recruiting
Amgen
Phase 3
24
Florence
2019-12-20
Recruiting
Merck Sharp & Dohme LLC
Observational
1,065
Florence, Milan, Roma
2019-12-19
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
450
Florence, Milan, Roma
2019-12-19
Active, closed
Gruppo Italiano Trapianto di Midollo Osseo
Phase 2
120
Cagliari, Naples, Ancona, Bari, Bologna, Brescia, Cuneo, Florence
2019-12-06
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Florence, Milan, Roma, Torino
2019-11-13
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
DrugsDinutuximab Beta·Vindesine·Cyclophosphamid·Thiotepa
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
800
Bari, Brescia, Catania, Florence, Genova, Modena, Parma, Pavia
2019-11-05
Active, closed
Pediatric Long-Term Follow-up and Rollover Study
NCT03975829Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood
DrugsDabrafenib·Trametinib
Novartis Pharmaceuticals
Phase 4
163
Florence, Genova, Milan, Roma, Torino
2019-11-04
Active, closed
AstraZeneca
Phase 3
140
Cuneo, Florence, Milan, Naples, Roma, Torino
2019-10-29
Active, closed
Consorzio Oncotech
Observational
600
Aviano, Bari, Bergamo, Brindisi, Chieti, Como, Cuneo, Florence
2019-10-24
Active, closed
Novo Nordisk A/S
Phase 3
134
Florence, Castelfranco Veneto, Milan, Udine, Verona
2019-10-21
Active, closed
Biogen
Phase 3
152
Florence, Naples
2019-10-18
Active, closed
Eli Lilly and Company
Phase 3
30
Milan, Florence
2019-10-16
Recruiting
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 2
89
San Giovanni Rotondo, Bari, Bergamo, Bologna, Cagliari, Catania, Florence, Genova
2019-10-09
Active, closed
Pfizer
Phase 3
896
Castellana Grotte, Brescia, Milan, San Donato Milanese, Rho, Modena, Florence, Negrar(vr)
2019-09-05
Active, closed
Meyer Children's Hospital IRCCS
Observational
70
Florence
2019-09-01
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Ascoli Piceno, Brescia, Catania, Florence, Milan, Monza, Novara, Roma
2019-08-15
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
Florence, Allessandria, Bologna, Brindisi, Cagliari, Ferrara, Genoa, Lecce
2019-08-12
Active, closed
Pfizer
Phase 3
51
Florence, Naples
2019-07-29
Recruiting
Use of EBPT in Critically Ill Patients With AKI and/or Multiorgan Failure
NCT04033224Critical Illness, Acute Kidney Injury, Sepsis, Systemic Inflammatory Response Syndrome
Careggi Hospital
Observational
1,000
Empoli, Lido di Camaiore, Rozzano, San Donato Milanese, Monza, Brindisi, Florence, Pavia
2019-07-16
Recruiting
University of Milano Bicocca
Observational
7,000
Baggiovara, Bologna, Bolzano, Carate Brianza, Ferrara, Florence, Genova, Roma
2019-07-15
Active, closed
Dizal Pharmaceuticals
Phase 1/2
315
Aviano, Catania, Florence, Meldola, Milan, Parma, Ravenna, Reggio Emilia
2019-07-09
Active, closed
Novo Nordisk A/S
Phase 2
62
Florence, Genova, Milan, Roma
2019-07-04
Active, closed
Development of a Web-based Multicenter Registry on the Use of oXiris Membrane for EBPTs in Critically Ill Patients
NCT03807414Critical Illness, Acute Kidney Injury, Sepsis, Systemic Inflammatory Response Syndrome
Careggi Hospital
Observational
270
Esine, Empoli, San Donato Milanese, Benevento, Florence, Naples, Pavia, Perugia
2019-06-28
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
2,000
Acquaviva delle Fonti, Arezzo, Brescia, Florence, Milan, Negrar, Pavia, Perugia
2019-06-24
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Abano Terme, Acquaviva delle Fonti, Bassano del Grappa, Brescia, Chieti, Florence, Milan, Modena
2019-06-11
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Bergamo, Bologna, Brescia, Florence, L’Aquila, Milan, Naples, Rome
2019-06-04
Active, closed
IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
NCT03503409Myelodysplastic Syndromes, Acute Myeloid Leukemia
DrugIvosidenib
Groupe Francophone des Myelodysplasies
Phase 2
68
Alessandria, Ancona, Bologna, Brescia, Florence, Genova, Lecce, Milan
2019-05-14
Active, closed
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage, Retinopathy of Prematurity (ROP)
OHB Neonatology Ltd.
Phase 2
295
Milan, Padova, Florence, Genova, Treviso
2019-05-09
Active, closed
PROSpect: Prone and Oscillation Pediatric Clinical Trial
NCT03896763Acute Respiratory Distress Syndrome in Children
University of Pennsylvania
Not applicable
600
Florence, Rome, Genova
2019-05-01
Active, closed
Inspiris Resilia Durability Registry
NCT03666741Aortic Valve Stenosis
Institut für Pharmakologie und Präventive Medizin
Observational
400
Florence, Milan, Roma, Salerno
2019-04-26
Active, closed
AstraZeneca
Phase 3
810
Faenza, Florence, Milan, Naples, Roma, Verona
2019-04-16
By invitation
University of Edinburgh
Observational
287
Florence, Siena, Turin
2019-04-05
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Messina, Milan, Novara, Palermo, Roma, Bergamo, Florence, Pisa
2019-03-28
By invitation
Translation and Validation Fugl-Meyer in Italian Language
NCT03855618Validation Fugl Meyer Scale in Italian
Fondazione Don Carlo Gnocchi ETS
Observational
10
Florence
2019-03-15
Active, closed
AstraZeneca
Phase 3
724
Florence, Genova, Milan, Orbassano, Padova, Pavia, Roma, Rozzano
2019-03-06
Recruiting
RECORDATI GROUP
Observational
95
Florence, Milan, Monza, Naples, Padova, Turin
2019-01-15
Active, closed
AstraZeneca
Phase 2
367
Avellino, Florence, Milan, Orbassano, Padova, Parma, Perugia, Peschiera del Garda
2019-01-09
Active, closed
Vectorious Medical Technologies Ltd.
Not applicable
45
Florence
2019-01-08
Active, closed
Celgene
Phase 3
363
Orbassano, Bologna, Florence, Meldola, Milan, Padova, Reggio Calabria, Roma
2019-01-02
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Chieti, Milan, Turin, Bolzano, Florence, Arezzo, Bari, Genova
2018-12-24
Recruiting
Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas
NCT04621201Diagnosed or Relapsed/Refractory Sarcomas
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
Observational
120
Torino, Bologna, Florence, Genova, Milan, Pavia, Roma, Trieste
2018-12-06
Active, closed
AstraZeneca
Phase 3
825
Ancona, Bari, Bergamo, Florence, Milan, Monza, Padova, Roma
2018-12-06
Active, closed
AstraZeneca
Phase 3
1,063
Bari, Bologna, Florence, Milan, Naples, Orbassano, Pozzuoli, Verona
2018-11-16
Active, closed
IRCCS San Raffaele
Observational
200
Lecco, Milan, Modena, Roma, Florence, Sassari, Verona
2018-10-30
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Bologna, Florence, Messina, Roma, San Giovanni Rotondo, Trieste
2018-10-29
Recruiting
University of Florence
Not applicable
30
Florence
2018-10-01
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Chieti, Bari, Trieste, Rome, Milan, Torrette - Ancona, Florence, Perugia
2018-09-20
Recruiting
CNS Onlus
Phase 3
40
Florence
2018-05-20
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
Bologna, Florence, Genova, Milan, Monza, Naples, Pesaro, Rionero in Vulture PZ
2018-05-03
Active, closed
Bristol-Myers Squibb
Phase 3
545
Messina, Bologna, Florence, Meldola, Milan, Modena, Monserrato, Naples
2018-04-18
Active, closed
AbbVie
Phase 3
1,336
Torrette, Genoa, Rozzano, Milan, Rho, Rome, Florence, Negrar
2018-04-09
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Alessandria, Arezzo, Aviano, Bergamo, Brescia, Cremona, Florence, Genova
2018-03-23
Active, closed
Janssen Research & Development, LLC
Phase 2
136
Florence, Lecce, Milan, Naples, Province of Macerata
2018-03-02
Recruiting
Octapharma
Observational
200
Bari, Bologna, Castelfranco Veneto, Catania, Florence, Milan, Padova, Rome
2018-02-13
Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
NCT03328078Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma, Refractory Primary Central Nervous System Lymphoma
DrugsEmavusertib·Ibrutinib
Curis, Inc.
Phase 1/2
152
Cuneo, Florence, Meldola, Milan
2017-12-28
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
885
Florence, Meldola
2017-09-25
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Bari, Benevento, Bologna, Brindisi, Cagliari, Florence, Genova, Latina
2017-09-12
Active, closed
Takeda
Phase 1/2
59
Florence, Pavia, Roma, Torino
2017-09-06
Recruiting
Silvia Benemei
Observational
3,000
Florence
2017-09-01
Active, closed
Murdoch Childrens Research Institute
Phase 3
450
Alessandria, Bologna, Florence, Genova, Milan, Pisa, Roma
2017-08-10
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Bari, Bologna, Brescia, Florence, Forlì, Milan, Monza, Naples
2017-06-26
Recruiting
Italian Sarcoma Group
Not applicable
100
Milan, Bologna, Florence, Pavia, Pisa, Rome, Trento
2017-03-16
Active, closed
Acerta Pharma BV
Phase 3
310
Aviano, Bergamo, Brescia, Florence, Genova, Meldola, Milan, Modena
2017-02-02
Recruiting
Neurovascular Product Surveillance Registry
NCT02988128Intracranial Aneurysm, Stroke, Ischemic
Medtronic Neurovascular Clinical Affairs
Observational
4,000
Florence, Milan
2016-12
Recruiting
Observational Study on Endometrial Stromal Tumors
NCT02829437Endometrial Stromal Tumors
Italian Sarcoma Group
Observational
100
Meldola, Milan, Palermo, Aviano, Padova, Candiolo, Bologna, Florence
2016-10
Active, closed
Celgene
Phase 1/2
130
Bologna, Emilia-Romagna, Florence, Genova, Orbassano, Padova, Pesaro, Roma
2016-06-03
Recruiting
Meyer Children's Hospital IRCCS
Observational
900
Florence
2016-03-15
Active, closed
Geron Corporation
Phase 2/3
289
Milan, Rozzano, Rionero in Vulture, Roma, Ancona, Bologna, Florence, Reggio Calabria
2016-01-12
Active, closed
AstraZeneca
Phase 3
682
Bari, Bergamo, Bologna, Cremona, Florence, Lucca, Meldola, Milan
2015-10-21
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
Ferrara, Florence, Genoa, Grosseto, Legnago, Meldola, Milan, Monza
2015-08
Active, closed
Acerta Pharma BV
Phase 3
533
Bologna, Cagliari, Cona, Florence, Meldola, Milan, Modena, Ravenna
2015-07-28
Recruiting
Maurizio Tonetti
Not applicable
160
Florence
2015-07-12
Active, closed
Acerta Pharma BV
Phase 3
535
Alessandria, Aviano, Brescia, Florence, Meldola, Milan, Parma, Ravenna
2015-06-26
Active, closed
Ischaemic PReconditioning In Non Cardiac surgEry
NCT02427867Myocardial Ischemia, Surgery
Università Vita-Salute San Raffaele
Not applicable
1,217
Rozzano, Busto Arsizio, Asti, Florence, Genova, Milan, Naples, Pisa
2015-04
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Ancona, Bari, Bologna, Brescia, San Giovanni Rotondo, Florence, Milan, Rozzano
2015-03-05
By invitation
Registry of Patients With Hypophosphatasia
NCT02306720Hypophosphatasia (HPP)
Alexion Pharmaceuticals, Inc.
Observational
1,571
Sesto Fiorentino, Milan, Florence, Pisa, Rome, San Giovanni Rotondo
2015-01-20
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Bologna, Florence, Naples, Novara, Rome, Siena, Torino
2014-11
Recruiting
International Rare Histiocytic Disorders Registry (IRHDR)
NCT02285582Rare Histiocytic Disorders (RHDs), Erdheim-Chester Disease (ECD), Rosai-Dorfman Disease (RDD), Xanthogranuloma Family (XG)
The Hospital for Sick Children
Observational
400
Florence
2014-10
Recruiting
Arrhythmias Detection in a Real World Population
NCT02275637Appropriate and Inappropriate Shock Therapy With ICD, Arrhythmias Detection
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
10,000
Bergamo, Bologna, Catania, Florence, Milan, Naples, Padua, Pavia
2014-09
Recruiting
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
NCT02979119Factor VIII Deficiency, Factor IX Deficiency
PedNet Haemophilia Research Foundation
Observational
4,000
Florence, Genova, Milan
2014-06
Active, closed
University of Virginia
Observational
2,750
Bologna, Florence, Milan, Rome
2014-04
Recruiting
Weill Medical College of Cornell University
Not applicable
600
Florence, Rozzano, Naples
2014-03-12
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
NCT01633489Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
Alexion Pharmaceuticals, Inc.
Observational
300
Bari, Naples, Udine, Genoa, Bergamo, Milan, Turin, Florence
2013-05-30
Active, closed
AbbVie
Observational
8,250
Bologna, Florence, San Giovanni Rotondo, Genoa, Rozzano, Milan, Naples, Rome
2013-04-29
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Bologna, Florence, Genoa, Monza, Naples, Padova, Pavia, Pisa
2013-04
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Bari, Florence, Genova, Milan, Roma, Torino
2013-03-18
Active, closed
Italfarmaco
Phase 2
90
Bari, Bergamo, Florence, Milan, Pescara, Pavia, Reggio Calabria, Vicenza
2013-03
Active, closed
Bristol-Myers Squibb
Observational
800
Florence, Genova, Naples, Padova, Trento
2013-01-30
Active, closed
Washington University School of Medicine
Phase 2/3
490
Brescia, Florence
2012-12
Active, closed
Bristol-Myers Squibb
Observational
2,555
Pesaro, Ancona, Cagliari, Florence, Lecce, Messina, Milan, Naples
2012-06-13
Active, closed
Eli Lilly and Company
Phase 2
110
Bologna, Florence
2012-05-22
Recruiting
A European Network for the Investigation of Gender Incongruence
NCT01072825Physical and Psychological Evaluation of Hormonal Therapy in Transsexual Persons
DrugBlood sampling
University Hospital, Ghent
Observational
125
Florence
2010-02-15
Recruiting
Global Registry and Natural History Study for Mitochondrial Disorders
NCT05554835Mitochondrial Diseases, Kearns-Sayre Syndrome, MIDD, SANDO
LMU Klinikum
Observational
6,000
Bologna, Brescia, Cagliari, Florence, Genova, Messina, Milan, Pisa
2009-02-01
Recruiting
Esteve Pharmaceuticals, S.A.
Observational
500
Ancona, Bolzano, Brescia, Florence, Genova, Naples, Parma, Province of Macerata
2008-12-09
Recruiting
Pompe Pregnancy Sub-Registry
NCT00567073Glycogen Storage Disease Type II (GSD-II), Pompe Disease (Late-onset), Glycogenesis 2 Acid Maltase Deficiency
Genzyme, a Sanofi Company
Observational
20
Florence, Milan, Padua, Rome, Brescia, Cagliari, Genova, Messina
2007-06-18
Recruiting
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
NCT00315380Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome
University of Pennsylvania
Observational
700
Florence
2006-04
Recruiting
Pompe Disease Registry Protocol
NCT00231400Glycogen Storage Disease Type II, Pompe Disease
Genzyme, a Sanofi Company
Observational
2,000
Gussago, Cona, Florence, Milan, Padua, Rome, Brescia, Cagliari
2004-09-15
Recruiting
Post-Surgery Extracorporeal Life Support
NCT04330651Cardiogenic Shock, Extracorporeal Life Support, Extracorporeal Membrane Oxygenation Complication, Post Cardiac Arrest Syndrome
University of Florence
Observational
500
Florence
2004-01
Recruiting
Genzyme, a Sanofi Company
Observational
9,000
Florence, Milan, Baggiovara, Monza, Padua, Rome, Bassano del Grappa, Bologna
2001-07-31
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Florence, Milan, Baggiovara, Monza, Rome, Sassari, Catania, Genova
1991-04-01
Rows per page Showing 501–787 of 787
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/florence?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 787 of those studies with a site in Florence.

How many clinical trials are recruiting in Florence?

435 of the 787 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 30 have not yet opened recruitment, 305 are active but closed to new participants, and 17 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.